Nano-Oncology: Clinical Application for Cancer Therapy and Future Perspectives

<table class="table-group" id="tab9"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td align="left">Compound</td><td align="center">Name</td><td align="center">Status</td><td align="center">Indication</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td align="left">Albumin-paclitaxel</td><td align="center">Abraxane</td><td align="center">Approved</td><td align="center">Metastatic breast cancer</td></tr><tr><td align="left">Doxorubicin</td><td align="center">Transdrug</td><td align="center">Approved</td><td align="center">Hepatocarcinoma</td></tr><tr><td align="left">Paclitaxel</td><td align="center">Nanoxel</td><td align="center">Phase I</td><td align="center">Advanced breast cancer</td></tr><tr><td align="left">Paclitaxel</td><td align="center">Paclimer</td><td align="center">Phase I</td><td align="center">Various</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Examples of polymeric nanoparticles in clinical trials. 

Journal of Nanomaterials

tab9

Table 9

Table 9: Nano-Oncology: Clinical Application for Cancer Therapy and Future Perspectives 